The International Osteoporosis Foundation in cooperation with the Endocrine and Metabolic Society of Singapore (EMSS) and the Osteoporosis Society Singapore (OSS) look forward to welcoming you to the IOF Regionals 6th Asia-Pacific Osteoporosis Meeting taking place at the Singapore Convention & Exhibition Centre (Suntec) from November 4 – 6, 2016.
Why should you attend?
Health professionals in the Asia-Pacific are facing a rapidly ageing population. If you’re a physician, clinical researcher or allied health professional this key regional event will help you learn how to…
- identify patients at imminent high risk of fracture and how to prevent secondary fractures
- manage and treat osteoporosis, including through knowledge of the latest drug treatments and nutritional recommendations
- manage patients post-fracture (including fracture healing, orthobiologics, rehabilitation etc)
- address sarcopenia in your elderly patients by learning about the latest nutritional and physical recommendations
- manage bone loss in diabetics, transplantation patients, and cancer patients
Meet-the-Expert sessions, ‘speed dating’ with the professors and an interactive exhibition area will give delegates the opportunity to discuss with world experts, learn about the latest products and services, and mingle with the colleagues from throughout the region. The Meeting will also be the premier venue for the presentation of new research in the field, and particularly research from the region.
Preliminary Topics and Program
Bone and Diabetes
- Bone Fragility in Patients with Diabetes: Is it bone density or bone quality?
- Diabetes, Obesity and Bone Mineral Density – Asia Versus the West
- Clinical Management of Diabetes Patients with Osteoporosis
Emerging Concept I – Patients at Imminent High Risk
- What is the Profile of Patients at Imminent High Risk of Fracture?
- What is the Risk of Re-Fracture among Asians?
- Fracture Prevention in the Imminent High Risk Patients: What is the evidence (Subgroup Analyses of the RCTs)
- Biochemical Markers as Predictors of Bone Histomorphometric Alterations in Patients with Chronic Kidney Disease
- Genetic Risk Score based on the Prevalence of Vertebral Fracture in Japanese Women with Osteoporosis
Emerging Concept II – Treat-to-target
- Treat-to-target in Osteoporosis and Other Chronic Disorders: Opportunities and challenges
- Is Areal BMD a Good Surrogate to Evaluate Fracture Risk on Therapy?
- Current Strategies and Therapies to Improve Bone Strength (Incl. Combined Sequential Therapies)
IOF-ISCD Joint Session
- Non traditional/Novel DXA applications such as TBS, Hip Axis Length/FEA
- Fracture risk Assessment: Current use of FRAX in Asia-Pacific and its potential future modifications
- Best Practices for Dual-Energy X-ray Absorptiometry, Measurement and Reporting
Nutrition, Bone & Muscle
- Nutritional Aspects during Development: Scope for prevention of bone fragility
- Life Course Approach to Nutrition for Skeletal Health
- Nutritional and Physical Recommendations for Muscle Health in Seniors
- Cortical and Trabecular Deterioration Identify Women at Imminent Risk for Fracture: The prospective OFELY study
- Imminent Major Osteoporotic and Clinical Vertebral Fracture Risk after Fracture (Reykjavik Study)
- Fracture in the Elderly: Surgery or conservative management?
- What is the Evidence for Efficacy of Osteoporosis Drugs in the Elderly?
- How to Optimize Care in Hip Fracture Patients : The Singaporean experience
Post Fracture Management
- Management of Non-Union Fracture: New orthobiologics
- Atypical Femoral Fracture in Asia: How to prevent? How to treat?
- Non-Pharmacological Measures and Rehabilitation in Fractured Patients
- Treatment Patterns in Patients with Osteoporosis at High Risk of Fracture in Japan: A retrospective chart review
- Menopausal Bone Loss is mainly Cortical, not Trabecular, and does not attenuate the Heritable Component of Variance in this Microarchitecture: A prospective study of twins
- Towards an Operational Definition of Sarcopenia
- Nutrition and frailty in the Asian context — Vitamin D and other Nutrients
- Where are we in the Development of Treatments for Sarcopenia?
- Association between Statin Use and Change in Grip Strength among Community Dwelling Older Men and Women from Hong Kong MROS Cohort Study
- Longitudinal Study of Sarcopenic Obesity and Incident Falls and Fractures in Older Men: The concord health and ageing in men project
- Fracture Liaison Service decreases Mortality after Hip Fracture
- Long Term Management of Osteoporosis
- Novel Treatments: Odanacatib and anti-sclerostin antibodies
- New and Old PTH-Like Therapies for Osteoporosis: Abaloparatide and teriparatide
- Bone Health and Liver Disease — Are all Chronic Liver Diseases the same? S Khan*, S Hayat, A Bennett, N Guha, I Pande
- Identification of Chronic Joint Pain and Handgrip Strength as Independent Predictors of Osteoporosis in Middle-aged Singaporean Women
Young Investigator Award Session
- Promoter Hypermethylation Mediated Suppression of Cyclin Dependent Kinase Inhibitors (CDKN2A and CDKN2B) in Sporadic Parathyroid Tumors
- Moderate-to-vigorous Physical Activitiy but not Sedentary Time is associated with Musculoskeletal Health Outcomes in a Cohort of Australian Middle-aged Women
- Health Literacy and Uptake of Dietary Calcium Recommendations in Women
- The Improved Clinical Use of Trabecular Bone Score adjusted FRAX® to predict Major Osteoporotic Fractures in Chinese Older People
- Can ALP be the Surrogate Marker for Bone Turnover?
Singapore, November 2 – 3, 2016
IOF Young Investigator Award
IOF is dedicated to advancing scientific knowledge on osteoporosis, and in particular to encouraging young researchers in all parts of the world to focus on this important field. As a sign of this commitment, IOF is offering the presenting authors (40 years old or younger at the time of the Meeting) of the top five ranking abstracts submitted to the IOF Regionals ‒ 6th Asia-Pacific Osteoporosis Meeting their work at a special session on Saturday, November 5, 2016.
CME and CPE — Earn SMC and European CME Credits
The IOF Regionals Singapore ‘16’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
The ‘IOF Regionals Singapore ‘16’ is designated for a maximum of 22 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you only participate in the pre-meeting Osteoporosis Essentials Course, you should only claim 9 hours of European external CME Credits.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Singapore Medical Council Accreditation
The IOF Regionals, 6th Asia-Pacific Osteoporosis Meeting has been accredited a maximum of 9 CME/CPE points. Each health professional must claim only those credits that he/she actually spent in the activity. Attendees who wish to claim their SMC CME Credits need to sign and register their MCR numbers at the specific SMC desk (outside plenary room) at the beginning of each morning and afternoon sessions.
- Joon-Kiong Lee, Co-Chair, MYS
- John A. Kanis, Co-Chair, UK
Scientific Programme Committee
- Manju Chandran, Co-Chair, SGP
- Serge Ferrari, Co-Chair, CHE
- Siok-Bee Chionh, SGP
- Cyrus Cooper, UK
- Bess Dawson-Hughes, USA
- Tobias De Villiers, ZAF
- Peter Ebeling, AUS
- Hiroshi Hagino, JPN
- Andrew Ho, HKG
- Ko-En Huang, TWN
- John A. Kanis, UK
- Sarath Lekamwasam, SKA
- Xu Ling, CHN
- Ambrish Mithal, IND
- Shigeyuki Muraki, JPN
- Toshitaka Nakamura, JPN
- Dominique Pierroz, CHE
- Jean-Yves Reginster, BEL
- René Rizzoli, CHE
- Ego Seeman, AUS
- Atsushi Suzuki, JPN
- Nikhil Tandon, IND
- Chih-Hsing (Paulo) Wu, TWN
- Noriko Yoshimura, JPN
Local Organizing Committee
- Siok-Bee Chionh, Chair, SGP
- Seng Bin Ang, SGP
- Ding-Cheng (Derrick) Chan, TWN
- Fang Ping Chen, TWN
- Vivien Lim, SGP
- Alvin Ng, SGP